Surmodics Statistics
Total Valuation
Surmodics has a market cap or net worth of $567.74 million. The enterprise value is $560.87 million.
Important Dates
The next estimated earnings date is Thursday, January 30, 2025, before market open.
| Earnings Date | Jan 30, 2025 |
| Ex-Dividend Date | n/a |
Share Statistics
Surmodics has 14.33 million shares outstanding. The number of shares has increased by 0.87% in one year.
| Current Share Class | 14.33M |
| Shares Outstanding | 14.33M |
| Shares Change (YoY) | +0.87% |
| Shares Change (QoQ) | +0.13% |
| Owned by Insiders (%) | 4.09% |
| Owned by Institutions (%) | 77.74% |
| Float | 12.75M |
Valuation Ratios
| PE Ratio | n/a |
| Forward PE | n/a |
| PS Ratio | 4.45 |
| Forward PS | 3.96 |
| PB Ratio | 4.77 |
| P/TBV Ratio | 11.20 |
| P/FCF Ratio | n/a |
| P/OCF Ratio | 2,289.27 |
| PEG Ratio | n/a |
Financial Ratio HistoryEnterprise Valuation
| EV / Earnings | n/a |
| EV / Sales | 4.45 |
| EV / EBITDA | 83.10 |
| EV / EBIT | n/a |
| EV / FCF | n/a |
Financial Position
The company has a current ratio of 3.96, with a Debt / Equity ratio of 0.28.
| Current Ratio | 3.96 |
| Quick Ratio | 3.09 |
| Debt / Equity | 0.28 |
| Debt / EBITDA | 3.98 |
| Debt / FCF | n/a |
| Interest Coverage | -0.55 |
Financial Efficiency
Return on equity (ROE) is -9.67% and return on invested capital (ROIC) is -0.80%.
| Return on Equity (ROE) | -9.67% |
| Return on Assets (ROA) | -0.67% |
| Return on Capital (ROIC) | -0.80% |
| Revenue Per Employee | $324,108 |
| Profits Per Employee | -$29,671 |
| Employee Count | 389 |
| Asset Turnover | 0.69 |
| Inventory Turnover | 2.20 |
Taxes
In the past 12 months, Surmodics has paid $4.04 million in taxes.
| Income Tax | 4.04M |
| Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has increased by +9.02% in the last 52 weeks. The beta is 1.22, so Surmodics's price volatility has been higher than the market average.
| Beta (5Y) | 1.22 |
| 52-Week Price Change | +9.02% |
| 50-Day Moving Average | 39.00 |
| 200-Day Moving Average | 37.35 |
| Relative Strength Index (RSI) | 51.95 |
| Average Volume (20 Days) | 167,131 |
Short Selling Information
The latest short interest is 336,636, so 2.35% of the outstanding shares have been sold short.
| Short Interest | 336,636 |
| Short Previous Month | 337,837 |
| Short % of Shares Out | 2.35% |
| Short % of Float | 2.64% |
| Short Ratio (days to cover) | 1.87 |
Income Statement
In the last 12 months, Surmodics had revenue of $126.08 million and -$11.54 million in losses. Loss per share was -$0.82.
| Revenue | 126.08M |
| Gross Profit | 93.05M |
| Operating Income | -1.95M |
| Pretax Income | -9.16M |
| Net Income | -11.54M |
| EBITDA | 6.75M |
| EBIT | -1.95M |
| Loss Per Share | -$0.82 |
Full Income StatementBalance Sheet
The company has $40.11 million in cash and $33.24 million in debt, giving a net cash position of $6.87 million or $0.48 per share.
| Cash & Cash Equivalents | 40.11M |
| Total Debt | 33.24M |
| Net Cash | 6.87M |
| Net Cash Per Share | $0.48 |
| Equity (Book Value) | 118.90M |
| Book Value Per Share | 8.30 |
| Working Capital | 60.76M |
Full Balance SheetCash Flow
In the last 12 months, operating cash flow was $248,000 and capital expenditures -$3.49 million, giving a free cash flow of -$3.24 million.
| Operating Cash Flow | 248,000 |
| Capital Expenditures | -3.49M |
| Free Cash Flow | -3.24M |
| FCF Per Share | -$0.23 |
Full Cash Flow StatementMargins
Gross margin is 73.81%, with operating and profit margins of -1.54% and -9.15%.
| Gross Margin | 73.81% |
| Operating Margin | -1.54% |
| Pretax Margin | -5.95% |
| Profit Margin | -9.15% |
| EBITDA Margin | 5.35% |
| EBIT Margin | -1.54% |
| FCF Margin | n/a |
Dividends & Yields
Surmodics does not appear to pay any dividends at this time.
| Dividend Per Share | n/a |
| Dividend Yield | n/a |
| Dividend Growth (YoY) | n/a |
| Years of Dividend Growth | n/a |
| Payout Ratio | n/a |
| Buyback Yield | -0.87% |
| Shareholder Yield | -0.87% |
| Earnings Yield | -2.03% |
| FCF Yield | -0.57% |
Analyst Forecast
The average price target for Surmodics is $43.00, which is 8.50% higher than the current price. The consensus rating is "Hold".
| Price Target | $43.00 |
| Price Target Difference | 8.50% |
| Analyst Consensus | Hold |
| Analyst Count | 4 |
| Revenue Growth Forecast (5Y) | n/a |
| EPS Growth Forecast (5Y) | n/a |
Stock ForecastsStock Splits
The last stock split was on December 7, 2000. It was a forward split with a ratio of 2:1.
| Last Split Date | Dec 7, 2000 |
| Split Type | Forward |
| Split Ratio | 2:1 |
Scores
Surmodics has an Altman Z-Score of 6.66 and a Piotroski F-Score of 3.
| Altman Z-Score | 6.66 |
| Piotroski F-Score | 3 |